Latest Breaking News On - Tevogen bio - Page 1 : vimarsana.com

Tevogen Bio Appoints Tapan V Shah as Head of Investor

Mr. Shah, a Wall Street veteran with over 25 years of experience, brings broad leadership capabilities to Tevogen Bio....

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development

WARREN, N.J., April 03, 2024 -- Tevogen Bio Holdings Inc , a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development....

Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price

Tevogen Bio Announces Series A-1 Preferred Stock Investment

Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment

Tevogen Bio Holdings Inc. Tevogen’s ExacTcell platform was d...

Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market -February 17, 2024 at 12:18 am EST

Tevogen Bio Holdings Inc. celebrated commencement of its public trading by ringing the opening bell at the Nasdaq Stock Exchange...

Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market

WARREN, N.J.--(BUSINESS WIRE)--Feb 17, 2024--